MDXG News and Press, MiMedx Group Inc From 06/16/21

MARIETTA, Ga, June 16, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Of...

Proposed Mechanism Suggests Potential Path to Improve Outcomes in Clinical Applications where the Regulation of Excessive Fibrosis Can Promote a Normal Healing Response Complex Nature of MIMEDX dHACM May Prove Useful in a Multitude of Applications Where Normal Healing Is Impaire...

Mimedx Group (MDXG) announces successful regulatory approval by the Japanese Ministry of Health, Labour and Welfare ((JMHLW)) to market Epifix in Japan. Epifix - a bioabsorbable, human amniotic membrane allograft, is applied to affected areas for wound healing.The product uses proprietary met...

Availability of EPIFIX Allografts Expected Early 2022 Approval Makes it Possible to Bring EPIFIX’s Healing Properties to as Many as 100,000 New Patients Annually MARIETTA, Ga., June 08, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX&#...

4 Penny Stocks That Hit It Big In the Past Year As penny stocks investors, we love to see a company go from the under $5 mark to well beyond that number. While this is a rare occurrence, it does happen. And when it does, investors take note. Most of the time, those trading penny s...

Big hits from Bitcoin drops balanced out by a timely Virgin Galactic purchase means that May was anything but boring. A new trade is set up for the beginning of June as I build a smaller position into an overly-large one for a key upcoming catalyst. A portfolio built for individua...

MARIETTA, Ga., May 27, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer...

Deadline to Pre-Register Extended to May 26, 2021 at 10:00 a.m. Eastern Pre-Registration Required to Attend Annual Meeting Visit w ww.votemimedx.com for Instructions on How to Pre-Register MARIETTA, Ga., May 25, 2021 (GLOBE NEWSWIRE) -- MIMEDX G...

Vote FOR MIMEDX’s Experienced and Highly Qualified Directors and Governance Enhancement Proposals MARIETTA, Ga., May 12, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amnioti...

MiMedx Group (MDXG) has been issued a patent covering placental tissue composition for treating cardiac tissue damage.The company uses dehydrated amniotic tissue and placental-based tissue for wound and burn care, as well as surgical applications.MiMedx shares are up 0.5% to $9.51 i...